Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000667721 | SCV000792216 | likely pathogenic | Ellis-van Creveld syndrome | 2017-06-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001855487 | SCV002236427 | pathogenic | Ellis-van Creveld syndrome; Curry-Hall syndrome | 2024-01-18 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu354*) in the EVC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EVC are known to be pathogenic (PMID: 23220543). This variant is present in population databases (rs779915989, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with Ellis-van Creveld syndrome (PMID: 19810119). ClinVar contains an entry for this variant (Variation ID: 552459). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV001855487 | SCV002803600 | pathogenic | Ellis-van Creveld syndrome; Curry-Hall syndrome | 2021-09-18 | criteria provided, single submitter | clinical testing |